双滤器脑栓塞保护装置在胸主动脉腔内修复术中的超说明书使用
本文报告了2例接受胸主动脉腔内修复术(TEVAR)的高栓塞风险患者,超说明书使用双滤器脑栓塞保护装置(Sentinel)。两例均成功置入装置并完成手术,病理证实滤器捕获了栓塞碎片和纤维蛋白凝块,患者无神经功能缺损或装置相关并发症。
要点
- TEVAR围术期卒中风险为3%–8%,目前尚无FDA批准用于TEVAR的脑栓塞保护装置。
- 两例高栓塞风险患者超说明书使用Sentinel双滤器装置,均成功置入并完成手术。
- 病理证实滤器捕获栓塞碎片和纤维蛋白凝块,患者无神经功能缺损或装置相关并发症。
核心结论
- 双滤器脑栓塞保护装置在TEVAR中的超说明书使用是可行的,病理证实可捕获栓塞碎片,可能成为高危患者卒中预防的工具。
研究设计与样本
- 单中心两例病例报告,患者为高栓塞风险接受TEVAR的降主动脉胸段动脉瘤患者。
- 患者1为62岁女性,动脉瘤直径6.2 cm,累及左锁骨下动脉至膈肌(Zones 3-5),伴主动脉弓广泛粥样硬化病变。
- 患者2为78岁女性,动脉瘤直径6.3 cm,累及左锁骨下动脉(Zone 2)至第六肋间(Zone 4),伴附壁血栓。
主要发现
- 经右侧桡动脉 percutaneous 入路,使用6F鞘,将Sentinel双滤器装置经0.014″导丝送入胸主动脉。
- 两个滤器分别顺序部署于无名动脉和左颈总动脉,两例均成功置入合适尺寸的装置于近端和远端锚定区。
- 每例患者使用两个装置,完成造影显示动脉瘤成功隔绝,无内漏证据。
- 病理显示两例患者滤器均成功捕获栓塞碎片和纤维蛋白凝块。
- 两例患者均无神经功能缺损或装置相关并发症,分别在1个月和2个月随访时神经功能完好,监测造影显示动脉瘤成功隔绝无内漏。
临床怎么用
- 对于高栓塞风险的TEVAR患者,可考虑超说明书使用双滤器脑栓塞保护装置以预防围术期卒中。
- 装置经右侧桡动脉6F鞘送入,滤器部署于无名动脉和左颈总动脉,术后病理可确认栓塞碎片捕获。
局限性
- 仅两例病例报告,样本量小,结论的普遍性有限。
- 为超说明书使用,缺乏长期疗效和安全性数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The risk of periprocedural stroke after thoracic endovascular aortic repair (TEVAR) ranges from 3% to 8%. Although cerebral embolic protection devices (CEPD) are widely utilized in transcatheter aortic valve replacement, there are currently no Food and Drug Administration approved CEPDs for use in TEVAR. We report our initial experience with the off-label use of a dual-filter CEPD in patients undergoing TEVAR. METHODS: Two patients at high risk for embolic stroke underwent TEVAR for descending thoracic aortic aneurysms (DTAAs) at a single institution. A dual-filter CEPD (Sentinel; Boston Scientific, Marlborough, MA) was used in an off-label fashion in both cases. Patient 1 was a 62-year-old woman with a 6.2-cm DTAA, extending from the left subclavian artery (LSCA) to the diaphragm (Zones 3-5) and associated with extensive atherosclerotic disease of the aortic arch. Patient 2 was a 78-year-old woman with a 6.3-cm DTAA, extending from the LSCA (Zone 2) to the sixth intercostal space (Zone 4) with associated mural thrombus. Given the proximity of the aneurysm to the LSCA, a left carotid-subclavian bypass was performed for planned LSCA coverage. RESULTS: Through a percutaneous right radial artery approach using a 6F sheath, the Sentinel dual-filter CEPD was delivered over a 0.014″ guidewire into the thoracic aorta. Under fluoroscopic guidance, the 2 filters were sequentially deployed in the innominate and left common carotid arteries, respectively. Appropriately sized devices were successfully delivered and deployed in the proximal and distal landing zones, respectively. Two devices were used for each patient. Completion angiograms showed successful exclusion of the DTAAs in both cases, without evidence of endoleak. The CEPD filters were retrieved in standard fashion without difficulty. Pathology demonstrated successful capture of embolic debris and fibrin clot in both patients. Neither patient exhibited neurological deficits or device-related complications. Both patients remained neurologically intact at 1- and 2-month follow-up, respectively. Surveillance angiograms revealed successful exclusion of the aneurysm without any evidence of endoleak. CONCLUSIONS: We report the novel off-label use of a dual-filter CEPD in 2 patients undergoing TEVAR. Pathological confirmation of embolic debris in the filters makes this a potential tool for stroke prevention during TEVAR in high-risk patients.
引用
- Shah AS, Akhmerov A, Gupta N, et al. Use of a Dual-Filter Cerebral Embolic Protection Device in Thoracic Endovascular Aortic Repair. Ann Vasc Surg. 2020. PMID: 31981683. doi:10.1016/j.avsg.2020.01.077
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。